ALGERT GLOBAL LLC - CORVUS PHARMACEUTICALS INC ownership

CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 40 filers reported holding CORVUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALGERT GLOBAL LLC ownership history of CORVUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$72,000
+35.8%
14,949
-24.3%
0.01%
-44.4%
Q2 2021$53,000
-59.8%
19,737
-53.9%
0.02%
-57.1%
Q1 2021$132,000
+140.0%
42,857
+177.1%
0.04%
+162.5%
Q4 2020$55,000
+22.2%
15,467
+37.5%
0.02%
+14.3%
Q3 2020$45,000
+25.0%
11,247
-33.6%
0.01%
-6.7%
Q1 2020$36,00016,9470.02%
Other shareholders
CORVUS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 3,275,616$28,105,0004.42%
Novo Holdings A/S 4,420,516$37,928,0003.01%
BVF INC/IL 1,890,507$16,221,0001.42%
Orbimed Advisors 5,967,584$51,202,0000.62%
COWEN INC. 588,706$5,051,0000.46%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 108,000$710,0000.34%
SPHERA FUNDS MANAGEMENT LTD. 321,430$2,758,0000.32%
EcoR1 Capital, LLC 351,401$3,015,0000.27%
Rock Springs Capital Management LP 575,000$4,934,0000.18%
Hikari Power Ltd 32,090$275,0000.03%
View complete list of CORVUS PHARMACEUTICALS INC shareholders